<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2026-3-543-548</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-3059</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Преимущества имплантации ИОЛ с увеличенной глубиной фокуса (EDOF) при катаракте, ассоциированной с возрастной макулярной дегенерацией</article-title><trans-title-group xml:lang="en"><trans-title>The Advantages of Implantation EDOF Lenses in Cataracts Associated with Age-related Macular Degeneration</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5769-6593</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронин</surname><given-names>Г. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Voronin</surname><given-names>G. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воронин Григорий Викторович, доктор медицинских наук, ведущий научный сотрудник отдела патологии оптических сред глаза, профессор кафедры глазных болезней, заведующий отделением офтальмологии</p><p>ул. Россолимо, 11а, б, Москва, 119021,</p><p>ул. Трубецкая, 8, стр. 2, Москва, 119991,</p><p>ул. Староволынская, 10, Москва, 121352</p></bio><bio xml:lang="en"><p>Voronin Gregory V., MD, leading researcher, Professor, Department of pathology of optic media of the eye, head of Ophtalmology Department</p><p>Rossolimo str., 11A, B, Moscow, 119021,</p><p>Trubetskaya str., 8/2, Moscow, 119991,</p><p>Starovolynskaya str., 10, Moscow, 121352</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9191-020X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евдокимова</surname><given-names>A. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Evdokimova</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евдокимова Алена, Николаевна офтальмолог </p><p>ул. Староволынская, 10, Москва, 121352</p></bio><bio xml:lang="en"><p>Evdokimova Alyona N., ophtalmologist</p><p>Starovolynskaya str., 10, Moscow, 121352</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-4499-5159</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулагина</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulagina</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кулагина Надежда Валерьевна, аспирант, офтальмолог </p><p>ул. Россолимо, 11а, б, Москва, 119021,</p><p>ул. Староволынская, 10, Москва, 121352</p></bio><bio xml:lang="en"><p>Kulagina Nadezhda V., postgraduate, ophtalmologist</p><p>Rossolimo str., 11A, B, Moscow, 119021,</p><p>Starovolynskaya str., 10, Moscow, 121352</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-3089-2226</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чжан</surname><given-names>Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Chzhan</surname><given-names>Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чжан Шивэй, аспирант</p><p>ул. Трубецкая, 8, стр. 2, Москва, 119991</p></bio><bio xml:lang="en"><p>Chzhan Shiwei, postgraduate</p><p>Trubetskaya str., 8/2, Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней имени М.М. Краснова»;&#13;
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И. М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет);&#13;
ФГБУ «Клиническая больница № 1» (Волынская) Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.M. Krasnov Research Institute of Eye Diseases;&#13;
I.M. Sechenov First Moscow Medical University;&#13;
Clinical Hospital No. 1 (Volynskaya) of the Directorate of Presidential Affairs of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Клиническая больница № 1» (Волынская) Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Hospital No. 1 (Volynskaya) of the Directorate of Presidential Affairs of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней имени М.М. Краснова»;&#13;
ФГБУ «Клиническая больница № 1» (Волынская) Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.M. Krasnov Research Institute of Eye Diseases;&#13;
Clinical Hospital No. 1 (Volynskaya) of the Directorate of Presidential Affairs of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И. М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>05</day><month>10</month><year>2026</year></pub-date><volume>23</volume><issue>3</issue><fpage>543</fpage><lpage>548</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воронин Г.В., Евдокимова A.Н., Кулагина Н.В., Чжан Ш., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Воронин Г.В., Евдокимова A.Н., Кулагина Н.В., Чжан Ш.</copyright-holder><copyright-holder xml:lang="en">Voronin G.V., Evdokimova A.N., Kulagina N.V., Chzhan S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/3059">https://www.ophthalmojournal.com/opht/article/view/3059</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Катаракта и возрастная макулярная дегенерация (ВМД) — часто встречающаяся сочетанная патология у пациентов старшей возрастной группы. Выбор интраокулярной линзы (ИОЛ) у таких пациентов остается сложной задачей. Традиционно используемые монофокальные ИОЛ не удовлетворяют растущие запросы пациентов с ВМД на независимость от очков. Новая технология EDOF (extended depth of focus) занимает промежуточное положение между монофокальными и мультифокальными ИОЛ, обеспечивая расширенный диапазон зрения при минимальном количестве дисфотопсий.</p></sec><sec><title>Цель</title><p>Цель: на основе анализа литературных данных оценить преимущества имплантации линз EDOF у пациентов с катарактой, осложненной ВМД.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведен анализ публикаций в базах PubMed, Scopus, Web of Science, Google Scholar.</p></sec><sec><title>Результаты</title><p>Результаты. EDOF линзы демонстрируют высокую эффективность при оценке остроты зрения на дальнем и среднем расстоянии, сопровождаясь низкой частотой дисфотопсий у пациентов со здоровой сетчаткой. На ранних стадиях ВМД имплантация EDOF линз позволяет достичь удовлетворительных функциональных результатов, превосходящих показатели монофокальных ИОЛ. В то же время на поздних стадиях ВМД эффективность EDOF линз снижается пропорционально степени нарушения центрального зрения. Прогностическими факторами успеха являются исходная острота зрения, сохранность фовеолярной структуры по данным ОКТ и стабильное течение ВМД.</p></sec><sec><title>Заключение</title><p>Заключение. Имплантация ИОЛ с увеличенной глубиной фокуса (EDOF линзы) пациентам с возрастной макулярной дегенерацией является перспективным направлением для исследований. Отсутствие крупных проспективных исследований и недостаточная изученность отдаленных результатов не позволяют ввести четкий алгоритм отбора изучаемой группы пациентов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Relevance</title><p>Relevance. Cataracts and age–related macular degeneration (AMD) are a common combined pathology in patients of the older age group. Selecting an intraocular lens (IOL) in such patients remains a difficult task. Traditionally used monofocal IOLs do not satisfy the growing demands of AMD patients for eyeglass independence. The new EDOF (extended depth of focus) technology occupies an intermediate position between monofocal and multifocal IOLs, providing an extended range of vision with a minimum number of dysphotopsias.</p></sec><sec><title>Purpose</title><p>Purpose. Based on the analysis of literature data, to evaluate the advantages of EDOF lens implantation in patients with AMD-complicated cataracts.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The analysis of publications in the databases PubMed, Scopus, Web of Science, Google Scholar is carried out.</p></sec><sec><title>Results</title><p>Results. EDOF lenses demonstrate high efficiency in assessing longand medium-range visual acuity, accompanied by a low incidence of dysphotopsia in patients with healthy retinas. In the early stages of AMD, the implantation of EDOF lenses allows achieving satisfactory functional results that exceed the performance of monofocal IOLs. While in the late stages of AMD, the effectiveness of EDOF lenses decreases in proportion to the degree of central vision impairment. The prognostic success factors are the initial visual acuity, the preservation of the foveolar structure according to OCT data, and the stable course of AMD.</p></sec><sec><title>Conclusion</title><p>Conclusion. The implantation of IOLs with extended depth of focus (EDOF lenses) in patients with age-related macular degeneration is a promising area of research. The lack of large prospective studies and insufficient knowledge of long-term results do not allow us to introduce a clear algorithm for selecting the studied group of patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>экстракция катаракты</kwd><kwd>увеличенная глубина фокуса</kwd><kwd>EDOF</kwd><kwd>трифокальные ИОЛ</kwd><kwd>интраокулярная линза</kwd><kwd>возрастная макулярная дегенерация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cataract extraction</kwd><kwd>extended depth of focus</kwd><kwd>EDOF</kwd><kwd>trifocal IOLs</kwd><kwd>intraocular lens</kwd><kwd>age-related macular degeneration</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya’ale D, Négrel AD, Resnikoff S. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004 Apr;11(2):67–115. doi: 10.1076/opep.11.2.67.28158.</mixed-citation><mixed-citation xml:lang="en">Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya’ale D, Négrel AD, Resnikoff S. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004 Apr;11(2):67–115. doi: 10.1076/opep.11.2.67.28158.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Weill Y, Hanhart J, Zadok D, Smadja D, Gelman E, Abulafia A. Patient management modifications in cataract surgery candidates following incorporation of routine preoperative macular optical coherence tomography. J Cataract Refract Surg. 2021 Jan 1;47(1):78–82. doi: 10.1097/j.jcrs.0000000000000389.</mixed-citation><mixed-citation xml:lang="en">Weill Y, Hanhart J, Zadok D, Smadja D, Gelman E, Abulafia A. Patient management modifications in cataract surgery candidates following incorporation of routine preoperative macular optical coherence tomography. J Cataract Refract Surg. 2021 Jan 1;47(1):78–82. doi: 10.1097/j.jcrs.0000000000000389.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Javitt JC, Steinberg EP, Sharkey P, Schein OD, Tielsch JM, Diener M, Legro M, Sommer A. Cataract surgery in one eye or both. A billion dollar per year issue. Ophthalmology. 1995 Nov;102(11):1583–1592; discussion 1592–1593. doi: 10.1016/s01616420(95)30824-x.</mixed-citation><mixed-citation xml:lang="en">Javitt JC, Steinberg EP, Sharkey P, Schein OD, Tielsch JM, Diener M, Legro M, Sommer A. Cataract surgery in one eye or both. A billion dollar per year issue. Ophthalmology. 1995 Nov;102(11):1583–1592; discussion 1592–1593. doi: 10.1016/s01616420(95)30824-x.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Marchesi N, Capierri M, Pascale A, Barbieri A. Different Therapeutic Approaches for Dry and Wet AMD. Int J Mol Sci. 2024 Dec 4;25(23):13053. doi: 10.3390/ijms252313053.</mixed-citation><mixed-citation xml:lang="en">Marchesi N, Capierri M, Pascale A, Barbieri A. Different Therapeutic Approaches for Dry and Wet AMD. Int J Mol Sci. 2024 Dec 4;25(23):13053. doi: 10.3390/ijms252313053.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014 Feb;2(2):e106–116. doi: 10.1016/S2214-109X(13)70145-1.</mixed-citation><mixed-citation xml:lang="en">Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014 Feb;2(2):e106–116. doi: 10.1016/S2214-109X(13)70145-1.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew EY. Age-related macular degeneration. Nat Rev Dis Primers. 2021 May 6;7(1):31. doi: 10.1038/s41572-021-00265-2.</mixed-citation><mixed-citation xml:lang="en">Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew EY. Age-related macular degeneration. Nat Rev Dis Primers. 2021 May 6;7(1):31. doi: 10.1038/s41572-021-00265-2.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pauleikhoff D. neovascular age-related macular degeneration: Natural History and Treatment Outcomes. Retina. 2005 Dec;25(8):1065–1084. doi: 10.1097/00006982200512000-00016.</mixed-citation><mixed-citation xml:lang="en">Pauleikhoff D. neovascular age-related macular degeneration: Natural History and Treatment Outcomes. Retina. 2005 Dec;25(8):1065–1084. doi: 10.1097/00006982200512000-00016.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial. Ophthalmology. 2021 Apr;128(4):576–586. doi: 10.1016/j.ophtha.2020.08.027.</mixed-citation><mixed-citation xml:lang="en">Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial. Ophthalmology. 2021 Apr;128(4):576–586. doi: 10.1016/j.ophtha.2020.08.027.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Klein BE. Is the risk of incidence or progression of age-related macular degeneration increased after cataract surgery? Arch Ophthalmol. 2009 Nov;127(11):1528– 1529. doi: 10.1001/archophthalmol.2009.258.</mixed-citation><mixed-citation xml:lang="en">Klein BE. Is the risk of incidence or progression of age-related macular degeneration increased after cataract surgery? Arch Ophthalmol. 2009 Nov;127(11):1528– 1529. doi: 10.1001/archophthalmol.2009.258.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sutter FK, Menghini M, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Bosch MM, Helbig H. Is pseudophakia a risk factor for neovascular age-related macular degeneration? Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1472–1475. doi: 10.1167/iovs.06-0766.</mixed-citation><mixed-citation xml:lang="en">Sutter FK, Menghini M, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Bosch MM, Helbig H. Is pseudophakia a risk factor for neovascular age-related macular degeneration? Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1472–1475. doi: 10.1167/iovs.06-0766.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wang JJ, Fong CS, Rochtchina E, Cugati S, de Loryn T, Kaushik S, Tan JS, Arnold J, Smith W, Mitchell P. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons. Ophthalmology. 2012 Nov;119(11):2298–2303. doi: 10.1016/j.ophtha.2012.07.003.</mixed-citation><mixed-citation xml:lang="en">Wang JJ, Fong CS, Rochtchina E, Cugati S, de Loryn T, Kaushik S, Tan JS, Arnold J, Smith W, Mitchell P. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons. Ophthalmology. 2012 Nov;119(11):2298–2303. doi: 10.1016/j.ophtha.2012.07.003.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ho JD, Xirasagar S, Kao LT, Lin HC. Neovascular age-related macular degeneration is associated with cataract surgery. Acta Ophthalmol. 2018 Mar;96(2):e213–e217. doi: 10.1111/aos.13511.</mixed-citation><mixed-citation xml:lang="en">Ho JD, Xirasagar S, Kao LT, Lin HC. Neovascular age-related macular degeneration is associated with cataract surgery. Acta Ophthalmol. 2018 Mar;96(2):e213–e217. doi: 10.1111/aos.13511.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Daien V, Nguyen V, Morlet N, Arnold JJ, Essex RW, Young S, Hunyor A, Gillies MC, Barthelmes D; Fight Retinal Blindness! Study Group. Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project. Am J Ophthalmol. 2018 Jun;190:50–57. doi: 10.1016/j.ajo.2018.03.012.</mixed-citation><mixed-citation xml:lang="en">Daien V, Nguyen V, Morlet N, Arnold JJ, Essex RW, Young S, Hunyor A, Gillies MC, Barthelmes D; Fight Retinal Blindness! Study Group. Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project. Am J Ophthalmol. 2018 Jun;190:50–57. doi: 10.1016/j.ajo.2018.03.012.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Park SJ, Lee JH, Ahn S, Park KH. Cataract Surgery and Age-Related Macular Degeneration in the 2008-2012 Korea National Health and Nutrition Examination Survey. JAMA Ophthalmol. 2016 Jun 1;134(6):621–626. doi: 10.1001/jamaophthalmol.2016.0453.</mixed-citation><mixed-citation xml:lang="en">Park SJ, Lee JH, Ahn S, Park KH. Cataract Surgery and Age-Related Macular Degeneration in the 2008-2012 Korea National Health and Nutrition Examination Survey. JAMA Ophthalmol. 2016 Jun 1;134(6):621–626. doi: 10.1001/jamaophthalmol.2016.0453.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ehmann DS, Ho AC. Cataract surgery and age-related macular degeneration. Curr Opin Ophthalmol. 2017 Jan;28(1):58–62. doi: 10.1097/ICU.0000000000000331.</mixed-citation><mixed-citation xml:lang="en">Ehmann DS, Ho AC. Cataract surgery and age-related macular degeneration. Curr Opin Ophthalmol. 2017 Jan;28(1):58–62. doi: 10.1097/ICU.0000000000000331.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L, Li H, Zhao X, Pan Y. Association between Cataract Surgery and Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. J Ophthalmol. 2022 May 5;2022:6780901. doi: 10.1155/2022/6780901.</mixed-citation><mixed-citation xml:lang="en">Yang L, Li H, Zhao X, Pan Y. Association between Cataract Surgery and Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. J Ophthalmol. 2022 May 5;2022:6780901. doi: 10.1155/2022/6780901.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kessel L, Erngaard D, Flesner P, Andresen J, Tendal B, Hjortdal J. Cataract surgery and age-related macular degeneration. An evidence-based update. Acta Ophthalmol. 2015 Nov;93(7):593–600. doi: 10.1111/aos.12665.</mixed-citation><mixed-citation xml:lang="en">Kessel L, Erngaard D, Flesner P, Andresen J, Tendal B, Hjortdal J. Cataract surgery and age-related macular degeneration. An evidence-based update. Acta Ophthalmol. 2015 Nov;93(7):593–600. doi: 10.1111/aos.12665.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">de Jong PT. Age-related macular degeneration. N Engl J Med. 2006 Oct 5;355(14): 1474–1485. doi: 10.1056/NEJMra062326.</mixed-citation><mixed-citation xml:lang="en">de Jong PT. Age-related macular degeneration. N Engl J Med. 2006 Oct 5;355(14): 1474–1485. doi: 10.1056/NEJMra062326.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Forooghian F, Agrón E, Clemons TE, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Research Group. Visual acuity outcomes after cataractsurgery in patients with age-related macular degeneration: age-related eye disease study report no. 27. Ophthalmology. 2009 Nov;116(11):2093–2100. doi: 10.1016/j.ophtha.2009.04.033.</mixed-citation><mixed-citation xml:lang="en">Forooghian F, Agrón E, Clemons TE, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Research Group. Visual acuity outcomes after cataractsurgery in patients with age-related macular degeneration: age-related eye disease study report no. 27. Ophthalmology. 2009 Nov;116(11):2093–2100. doi: 10.1016/j.ophtha.2009.04.033.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Age-Related Eye Disease Study 2 Research Group; Huynh N, Nicholson BP, Agrón E, Clemons TE, Bressler SB, Rosenfeld PJ, Chew EY. Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. Ophthalmology. 2014 Jun;121(6):1229–1236. doi: 10.1016/j.ophtha.2013.12.035.</mixed-citation><mixed-citation xml:lang="en">Age-Related Eye Disease Study 2 Research Group; Huynh N, Nicholson BP, Agrón E, Clemons TE, Bressler SB, Rosenfeld PJ, Chew EY. Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. Ophthalmology. 2014 Jun;121(6):1229–1236. doi: 10.1016/j.ophtha.2013.12.035.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenfeld PJ, Shapiro H, Ehrlich JS, Wong P; MARINA and ANCHOR Study Groups. Cataract surgery in ranibizumab-treated patients with neovascular agerelated macular degeneration from the phase 3 ANCHOR and MARINA trials. Am J Ophthalmol. 2011 Nov;152(5):793–798. doi: 10.1016/j.ajo.2011.04.025.</mixed-citation><mixed-citation xml:lang="en">Rosenfeld PJ, Shapiro H, Ehrlich JS, Wong P; MARINA and ANCHOR Study Groups. Cataract surgery in ranibizumab-treated patients with neovascular agerelated macular degeneration from the phase 3 ANCHOR and MARINA trials. Am J Ophthalmol. 2011 Nov;152(5):793–798. doi: 10.1016/j.ajo.2011.04.025.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lundström M, Brege KG, Florén I, Lundh B, Stenevi U, Thorburn W. Cataract surgery and quality of life in patients with age related macular degeneration. Br J Ophthalmol. 2002 Dec;86(12):1330–1335. doi: 10.1136/bjo.86.12.1330.</mixed-citation><mixed-citation xml:lang="en">Lundström M, Brege KG, Florén I, Lundh B, Stenevi U, Thorburn W. Cataract surgery and quality of life in patients with age related macular degeneration. Br J Ophthalmol. 2002 Dec;86(12):1330–1335. doi: 10.1136/bjo.86.12.1330.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Morris D, Fraser SG, Gray C. Cataract surgery and quality of life implications. Clin Interv Aging. 2007;2(1):105–108. doi: 10.2147/ciia.2007.2.1.105.</mixed-citation><mixed-citation xml:lang="en">Morris D, Fraser SG, Gray C. Cataract surgery and quality of life implications. Clin Interv Aging. 2007;2(1):105–108. doi: 10.2147/ciia.2007.2.1.105.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Taipale C, Grzybowski A, Tuuminen R. Effect of cataract surgery on quality of life for patients with severe vision impairment due to age-related macular degeneration. Ann Transl Med. 2020 Nov;8(22):1543. doi: 10.21037/atm-2020-965.</mixed-citation><mixed-citation xml:lang="en">Taipale C, Grzybowski A, Tuuminen R. Effect of cataract surgery on quality of life for patients with severe vision impairment due to age-related macular degeneration. Ann Transl Med. 2020 Nov;8(22):1543. doi: 10.21037/atm-2020-965.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Feng YR, Meuleners LB, Fraser ML, Brameld KJ, Agramunt S. The impact of first and second eye cataract surgeries on falls: a prospective cohort study. Clin Interv Aging. 2018 Aug 23;13:1457–1464. doi: 10.2147/CIA.S164419.</mixed-citation><mixed-citation xml:lang="en">Feng YR, Meuleners LB, Fraser ML, Brameld KJ, Agramunt S. The impact of first and second eye cataract surgeries on falls: a prospective cohort study. Clin Interv Aging. 2018 Aug 23;13:1457–1464. doi: 10.2147/CIA.S164419.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Yeu E, Cuozzo S. Matching the patient to the intraocular lens: Preoperative considerations to optimize surgical outcomes. Ophthalmology. 2021;128:e132–141. doi: 10.1016/j.ophtha.2020.08.025.</mixed-citation><mixed-citation xml:lang="en">Yeu E, Cuozzo S. Matching the patient to the intraocular lens: Preoperative considerations to optimize surgical outcomes. Ophthalmology. 2021;128:e132–141. doi: 10.1016/j.ophtha.2020.08.025.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Alio JL, Plaza-Puche AB, Férnandez-Buenaga R, Pikkel J, Maldonado M. Multifocal intraocular lenses: An overview. Surv Ophthalmol. 2017 Sep-Oct;62(5):611–634. doi: 10.1016/j.survophthal.2017.03.005.</mixed-citation><mixed-citation xml:lang="en">Alio JL, Plaza-Puche AB, Férnandez-Buenaga R, Pikkel J, Maldonado M. Multifocal intraocular lenses: An overview. Surv Ophthalmol. 2017 Sep-Oct;62(5):611–634. doi: 10.1016/j.survophthal.2017.03.005.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Banta JT, Rosenfeld PJ. Cataract surgery and intraocular lens selection in patients with age-related macular degeneration: pearls for success. Int Ophthalmol Clin. 2012 Spring;52(2):73–80. doi: 10.1097/IIO.0b013e31824b3ed3.</mixed-citation><mixed-citation xml:lang="en">Banta JT, Rosenfeld PJ. Cataract surgery and intraocular lens selection in patients with age-related macular degeneration: pearls for success. Int Ophthalmol Clin. 2012 Spring;52(2):73–80. doi: 10.1097/IIO.0b013e31824b3ed3.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Zamora-de La Cruz D, Zúñiga-Posselt K, Bartlett J, Gutierrez M, Abariga SA. Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia. Cochrane Database Syst Rev. 2020 Jun 18;6(6):CD012648. doi: 10.1002/14651858.CD012648.pub2. Update in: Cochrane Database Syst Rev. 2023 Jan 27;1:CD012648. doi: 10.1002/14651858.CD012648.pub3.</mixed-citation><mixed-citation xml:lang="en">Zamora-de La Cruz D, Zúñiga-Posselt K, Bartlett J, Gutierrez M, Abariga SA. Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia. Cochrane Database Syst Rev. 2020 Jun 18;6(6):CD012648. doi: 10.1002/14651858.CD012648.pub2. Update in: Cochrane Database Syst Rev. 2023 Jan 27;1:CD012648. doi: 10.1002/14651858.CD012648.pub3.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Regan D, Neima D. Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson’s disease. Br J Ophthalmol. 1984;68:885– 889. doi: 10.1136/bjo.68.12.885.</mixed-citation><mixed-citation xml:lang="en">Regan D, Neima D. Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson’s disease. Br J Ophthalmol. 1984;68:885– 889. doi: 10.1136/bjo.68.12.885.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kamath G, Prasad S, Danson A, Phillips R. Visual outcome with the array multifocal intraocular lens in patients with concurrent eye disease. J Cataract Refract Surg. 2000;26:576–81. doi: 10.1016/s0886-3350(99)00457-5.</mixed-citation><mixed-citation xml:lang="en">Kamath G, Prasad S, Danson A, Phillips R. Visual outcome with the array multifocal intraocular lens in patients with concurrent eye disease. J Cataract Refract Surg. 2000;26:576–81. doi: 10.1016/s0886-3350(99)00457-5.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Gayton J, Mackool R, Ernest P, Seabolt R, Dumont S. Implantation of multifocal intraocular lenses using a magnification strategy in cataractous eyes with age-related macular degeneration. J Cataract Refract Surg. 2012;38:415–418. doi: 10.1016/j.jcrs.2011.12.022.</mixed-citation><mixed-citation xml:lang="en">Gayton J, Mackool R, Ernest P, Seabolt R, Dumont S. Implantation of multifocal intraocular lenses using a magnification strategy in cataractous eyes with age-related macular degeneration. J Cataract Refract Surg. 2012;38:415–418. doi: 10.1016/j.jcrs.2011.12.022.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Grzybowski A, Kanclerz P, Tuuminen R. Multifocal intraocular lenses and retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2020;258:805–13. doi: 10.1007/s00417-020-04603-0.</mixed-citation><mixed-citation xml:lang="en">Grzybowski A, Kanclerz P, Tuuminen R. Multifocal intraocular lenses and retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2020;258:805–13. doi: 10.1007/s00417-020-04603-0.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Rocha KM. Extended Depth of Focus IOLs: The Next Chapter in Refractive Technology? Journal of Refractive Surgery. 2017;33(3):146–149. doi: 10.3928/1081597X20170217-01.</mixed-citation><mixed-citation xml:lang="en">Rocha KM. Extended Depth of Focus IOLs: The Next Chapter in Refractive Technology? Journal of Refractive Surgery. 2017;33(3):146–149. doi: 10.3928/1081597X20170217-01.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ozulken K, Kiziltoprak H, Yuksel E, Mumcuoğlu T. A Comparative Evaluation of Diffractive Trifocal and New Refractive/Extended Depth of Focus Intraocular Lenses for Refractive Lens Exchange. Curr Eye Res. 2021 Jun;46(6):811–817. doi: 10.1080/02713683.2020.1833347.</mixed-citation><mixed-citation xml:lang="en">Ozulken K, Kiziltoprak H, Yuksel E, Mumcuoğlu T. A Comparative Evaluation of Diffractive Trifocal and New Refractive/Extended Depth of Focus Intraocular Lenses for Refractive Lens Exchange. Curr Eye Res. 2021 Jun;46(6):811–817. doi: 10.1080/02713683.2020.1833347.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Dong Y, Wang Y. Efficacy and safety of extended depth of focus intraocular lenses in cataract surgery: A systematic review and meta-analysis. BMC Ophthalmol. 2019;19:198. doi: 10.1186/s12886-019-1204-0.</mixed-citation><mixed-citation xml:lang="en">Liu J, Dong Y, Wang Y. Efficacy and safety of extended depth of focus intraocular lenses in cataract surgery: A systematic review and meta-analysis. BMC Ophthalmol. 2019;19:198. doi: 10.1186/s12886-019-1204-0.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Mencucci R, Favuzza E, Caporossi O, Savastano A, Rizzo S. Comparative analysis of visual outcomes, reading skills, contrast sensitivity, and patient satisfaction with two models of trifocal diffractive intraocular lenses and an extended range of vision intraocular lens. Graefes Arch Clin Exp Ophthalmol. 2018;256:1913–1922. doi: 10.1007/s00417-018-4052-3.</mixed-citation><mixed-citation xml:lang="en">Mencucci R, Favuzza E, Caporossi O, Savastano A, Rizzo S. Comparative analysis of visual outcomes, reading skills, contrast sensitivity, and patient satisfaction with two models of trifocal diffractive intraocular lenses and an extended range of vision intraocular lens. Graefes Arch Clin Exp Ophthalmol. 2018;256:1913–1922. doi: 10.1007/s00417-018-4052-3.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Zhong Y, Wang K, Yu X, Liu X, Yao K. Comparison of trifocal or hybrid multifocalextended depth of focus intraocular lenses: A systematic review and meta-analysis. Sci Rep. 2021;11:6699. doi: 10.1038/s41598-021-86222-1.</mixed-citation><mixed-citation xml:lang="en">Zhong Y, Wang K, Yu X, Liu X, Yao K. Comparison of trifocal or hybrid multifocalextended depth of focus intraocular lenses: A systematic review and meta-analysis. Sci Rep. 2021;11:6699. doi: 10.1038/s41598-021-86222-1.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Guo Y, Wang Y, Hao R, Jiang X, Liu Z, Li X. Comparison of patient outcomes following implantation of trifocal and extended depth of focus intraocular lenses: A systematic review and meta-analysis. J Ophthalmol. 2021;2021:1115076. doi: 10.1155/2021/1115076.</mixed-citation><mixed-citation xml:lang="en">Guo Y, Wang Y, Hao R, Jiang X, Liu Z, Li X. Comparison of patient outcomes following implantation of trifocal and extended depth of focus intraocular lenses: A systematic review and meta-analysis. J Ophthalmol. 2021;2021:1115076. doi: 10.1155/2021/1115076.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Karam M, Alkhowaiter N, Alkhabbaz A, Aldubaikhi A, Alsaif A, Shareef E, et al. Extended depth of focus versus trifocal for intraocular lens implantation: An updated systematic review and meta-analysis. Am J Ophthalmol. 2023;251:52–70. doi: 10.1016/j.ajo.2023.01.024.</mixed-citation><mixed-citation xml:lang="en">Karam M, Alkhowaiter N, Alkhabbaz A, Aldubaikhi A, Alsaif A, Shareef E, et al. Extended depth of focus versus trifocal for intraocular lens implantation: An updated systematic review and meta-analysis. Am J Ophthalmol. 2023;251:52–70. doi: 10.1016/j.ajo.2023.01.024.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bhandari S, Chew E. Cataract surgery and the risk of progression of macular degeneration. Curr Opin Ophthalmol. 2023;34:27–31. doi: 10.1097/ICU.0000000000000909.</mixed-citation><mixed-citation xml:lang="en">Bhandari S, Chew E. Cataract surgery and the risk of progression of macular degeneration. Curr Opin Ophthalmol. 2023;34:27–31. doi: 10.1097/ICU.0000000000000909.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Thananjeyan A, Siu A, Jennings A, Bala C. Extended depth-of-focus intraocular lens implantation in patients with age-related macular degeneration: A pilot study. Clin Ophthalmol. 2024;18:451–458. doi: 10.2147/OPTH.S442931.</mixed-citation><mixed-citation xml:lang="en">Thananjeyan A, Siu A, Jennings A, Bala C. Extended depth-of-focus intraocular lens implantation in patients with age-related macular degeneration: A pilot study. Clin Ophthalmol. 2024;18:451–458. doi: 10.2147/OPTH.S442931.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Elvira JC, Devesa P, Elvira-Giner B, Tañá-Sanz P, Orts-Vila P, Tañá-Rivero P. Visual outcomes with a non-diffractive enhanced depth-of-focus IOL in patients with age-related macular degeneration. Front Med (Lausanne). 2025 Jun 13;12:1505401. doi: 10.3389/fmed.2025.1505401.</mixed-citation><mixed-citation xml:lang="en">Elvira JC, Devesa P, Elvira-Giner B, Tañá-Sanz P, Orts-Vila P, Tañá-Rivero P. Visual outcomes with a non-diffractive enhanced depth-of-focus IOL in patients with age-related macular degeneration. Front Med (Lausanne). 2025 Jun 13;12:1505401. doi: 10.3389/fmed.2025.1505401.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">SaadA, Findl O, Kretz F, Breyer DRH. Use of Partial Range of Field Intraocular Lenses in Eyes with Macular Disease. Klin Monbl Augenheilkd. 2025 Dec;242(12):1219– 1223. doi: 10.1055/a-2689-4769.</mixed-citation><mixed-citation xml:lang="en">SaadA, Findl O, Kretz F, Breyer DRH. Use of Partial Range of Field Intraocular Lenses in Eyes with Macular Disease. Klin Monbl Augenheilkd. 2025 Dec;242(12):1219– 1223. doi: 10.1055/a-2689-4769.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
